Back to top
more

HCA Healthcare (HCA)

(Real Time Quote from BATS)

$319.00 USD

319.00
383,718

+2.02 (0.64%)

Updated Jul 16, 2024 11:10 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 7% (17 out of 250)

Industry: Medical - Hospital

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Universal Health (UHS) Gains From Solid Segmental Performance

by Zacks Equity Research

Universal Health (UHS) gains from the uptrend in revenue growth, which in turn, is derived from expanding patient volumes. A credible financial position drives its expansion endeavors.

HCA Healthcare (HCA) Rises 24% in a Year: More Room to Run?

by Zacks Equity Research

HCA Healthcare (HCA) is well-poised for growth on the back of improved patient occupancy levels, effective telehealth services suite and solid cash-generating abilities.

Cigna (CI) Unit Ties Up to Offer Digital Health Tool to Clients

by Zacks Equity Research

Cigna's (CI) division, Cigna Healthcare, teams up with Virgin Pulse to make an effective digital health solution available to its clients, who can now improve their well-being.

The Zacks Analyst Blog Highlights JPMorgan Chase, Salesforce, Abbott Laboratories, HCA Healthcare and General Motors

by Zacks Equity Research

JPMorgan Chase, Salesforce, Abbott Laboratories, HCA Healthcare and General Motors are included in this Analyst Blog.

Sheraz Mian headshot

Top Stock Reports for JPMorgan Chase, Salesforce & Abbott Laboratories

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Salesforce, Inc. (CRM) and Abbott Laboratories (ABT).

Brookdale Senior (BKD) Shares Jump 18.7% Since Q2 Earnings Beat

by Zacks Equity Research

Brookdale Senior (BKD) expects adjusted EBITDA to be within the $73-$78 million range in the third quarter.

The Joint (JYNT) Reaches 900th Clinic Mark With New Texas Unit

by Zacks Equity Research

The Joint (JYNT) moves from the 800th to the 900th clinic milestone in less than a year.

Sanghamitra Saha headshot

4 Sector ETFs & Stocks to Play Despite Soft July Jobs Data

by Sanghamitra Saha

The U.S. economy added 187, 000 jobs in July of 2023, below market expectations of 200, 000.

Community Health (CYH) Q2 Earnings Top on Rising Admissions

by Zacks Equity Research

Community Health (CYH) expects net operating revenues in the range of $12,200 million-$12,600 million for 2023.

Pediatrix (MD) Q2 Earnings Meet Estimates, Revenues Up Y/Y

by Zacks Equity Research

Pediatrix (MD) reiterates adjusted EBITDA guidance in the range of $235-$245 million for 2023 compared with $241 million in 2022.

Humana (HUM) Q2 Earnings Beat on Strong Individual MA Unit

by Zacks Equity Research

Humana's (HUM) Q2 results gain from strong pharmacy revenues and revenue growth within the Insurance segment, partly offset by higher benefits expenses.

HCA Healthcare (HCA) Beats on Q2 Earnings, Ups 2023 EPS View

by Zacks Equity Research

HCA Healthcare's (HCA) Q2 results benefit from improving patient volumes and surgeries. However, rising expenses acted as a partial offset.

Compared to Estimates, HCA (HCA) Q2 Earnings: A Look at Key Metrics

by Zacks Equity Research

While the top- and bottom-line numbers for HCA (HCA) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

HCA Healthcare (HCA) Surpasses Q2 Earnings and Revenue Estimates

by Zacks Equity Research

HCA (HCA) delivered earnings and revenue surprises of 0.23% and 1.84%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks.com featured highlights KB Home, Caterpillar, Walmart, HCA Healthcare and Monolithic Power

by Zacks Equity Research

KB Home, Caterpillar, Walmart, HCA Healthcare and Monolithic Power have been highlighted in this Screen of The Week article.

Sweta Killa headshot

5 Dividend Stocks With Strong Growth Prospects to Buy

by Sweta Killa

KB Home (KBH), Caterpillar (CAT), Walmart (WMT), HCA Healthcare (HCA) and Monolithic Power (MPWR) could be compelling dividend picks for investors.

Will Higher Costs Affect HCA Healthcare's (HCA) Q2 Earnings?

by Zacks Equity Research

HCA Healthcare's (HCA) second-quarter results are likely to reflect increased patient volumes, occupancy rate and cost of supplies.

Philips (PHG) Q2 Earnings Beat Estimates, Revenue Rise Y/Y

by Zacks Equity Research

Philips' (PHG) second-quarter results benefit from robust performances by the Diagnosis & Treatment and the Connected Care businesses.

Mayur Thaker headshot

Investors Increasingly Betting on Soft Landing but the Fed Will Throw Cold Water

by Mayur Thaker

If the Fed continues to hike despite softening inflation and economic fundamentals, recession odds increase.

Select Medical (SEM) Expects Q2 Adjusted EBITDA to Jump 21% Y/Y

by Zacks Equity Research

Select Medical's (SEM) strong second-quarter 2023 guidance highlights improving performance in all four segments.

Horace Mann (HMN) Estimates Q2 Cat Loss Between $41M & $43M

by Zacks Equity Research

Horace Mann (HMN) estimates second-quarter catastrophe loss of $41-$43 million pre-tax, which is expected to contribute 26 to 27 points to the second-quarter combined ratio and weigh on the bottom line.

HCA Healthcare (HCA) Gains As Market Dips: What You Should Know

by Zacks Equity Research

HCA Healthcare (HCA) closed at $286.91 in the latest trading session, marking a +0.07% move from the prior day.

HCA Healthcare (HCA) Reports Next Week: Wall Street Expects Earnings Growth

by Zacks Equity Research

HCA (HCA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for FXH

Teladoc (TDOC) & Microsoft Partner to Reduce Administrative Woes

by Zacks Equity Research

Teladoc (TDOC) collaborates with Microsoft, enabling automatic clinical documentation with the help of AI.